Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.
Superinvestors holding AXSM, Q2 2026
No superinvestor reported holding AXSM in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of AXSM each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2023
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2023
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)